$11.98 WBA Walgreens Boots Alliance NASDAQ 26 Jan 2026 intraday: Volume spike

WBA stock trades at $11.98 on NASDAQ intraday on 26 Jan 2026, driven by a huge volume surge to 452,081,061.00 shares that places Walgreens Boots Alliance among the market’s most active names. The share price is up 0.50% from yesterday’s close of $11.92, trading above its 50-day average $11.66 and 200-day average $10.81. Intraday action reflects heavy retail and institutional interest, with the stock sitting between its 52-week high $13.25 and 52-week low $8.08 as investors weigh retail performance and pharmacy margins.

WBA stock intraday action and volume

Walgreens Boots Alliance (WBA) is the day’s most active Nasdaq name by raw volume, with 452,081,061.00 shares traded versus an average volume of 16,940,296.00. The relative volume of 26.69 signals an outsized move that is driving the intraday price to $11.98. The stock opened at $11.98, with intraday range fixed at $11.98 – $11.98 on the latest tick, and a modest change of $0.06 or 0.50%. Heavy volume often precedes volatility and trading-range extensions, so short-term traders should expect larger swings.

WBA stock fundamentals and valuation

Walgreens Boots Alliance reports trailing EPS of -7.29 and a trailing PE of -1.64, reflecting net losses on a per-share basis. Market capitalization stands at $10,369,421,068.00 and enterprise value at $38,637,421,068.00, producing a price-to-sales ratio of 0.07 and price-to-book of 1.44. Debt metrics are material: debt-to-equity is 4.04 and interest coverage is -6.13, underlining leverage pressure. The company shows positive operating cash flow per share $1.82 and free cash flow per share $0.67, which support operations despite profitability headwinds.

WBA stock technicals and trading signals

Short-term indicators show elevated momentum: RSI at 100.00 suggests the name is technically overbought intraday, while ADX at 50.00 implies a strong directional trend. Keltner Channels place the middle band at $11.93 and upper band at $12.26, framing near-term resistance. On-balance volume (OBV) at 452,081,061.00 confirms the volume-driven move. Traders should watch the 50-day average $11.66 and 200-day average $10.81 as key pullback support levels for intraday entries.

WBA stock: Meyka AI rating and forecast

Meyka AI rates WBA with a score out of 100: Meyka AI rates WBA with a score of 57.90 / 100 (Grade C+, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Analyst signals show Hold 1 and Sell 2 with a consensus score of 2.00. Meyka AI’s forecast model projects a one-year model price of $4.08, implying an estimated downside of -65.94% from the current $11.98. Forecasts are model-based projections and not guarantees. Investors should consider the grade alongside company leverage, cash flow, and near-term catalysts.

WBA stock outlook, price targets, and catalysts

Near-term catalysts include Walgreens’ next earnings announcement (expected 25 Jun 2025) and any updates on strategic reviews or asset sales. Market peers in the healthcare retail sector have shown mixed strength, and Walgreens’ membership in the DJIA has not insulated it from sector pressure. Reasonable price targets: conservative recovery target $13.00, baseline target $12.00, and downside support near $8.00 aligned with the 52-week low. Active traders may use the 50-day average $11.66 as a reference for stop placement and the 200-day average $10.81 as longer-term technical support. For details on short interest and dividend history see MarketBeat and related coverage source and the DJIA context at Investors.com source. Also view our internal Meyka WBA page for live metrics Meyka WBA page.

WBA stock risks and opportunities

Primary risks include elevated leverage (debt-to-equity 4.04), negative EPS -7.29, and tight liquidity (current ratio 0.60). Continued margin pressure or weaker pharmacy reimbursements would stress results. Opportunities include cost takeout, specialty pharmacy growth, and international portfolio moves that could unlock value. Short interest and active trading create volatility that can amplify both downside and upside moves for traders and portfolio managers.

Final Thoughts

Key takeaways on WBA stock: intraday action on 26 Jan 2026 shows a price of $11.98 and exceptional trading volume 452,081,061.00, making Walgreens Boots Alliance one of the market’s most active names. Fundamentals show weak profitability with EPS -7.29 and negative interest coverage, but positive operating cash flow supports short-term operations. Meyka AI rates WBA 57.90 / 100 (C+, HOLD) and its forecast model projects $4.08, implying a downside of approximately -65.94% versus the current price; forecasts are model-based and not guarantees. For active traders, use the 50-day average $11.66 and 200-day average $10.81 as reference points. For investors, the story hinges on balance-sheet repair and execution on strategic initiatives. Meyka AI-powered market analysis platform tracks these metrics in real time and updates ratings and forecasts as new data and catalysts emerge.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.